Open access
Sep 2026
Real-World Effectiveness and Safety of Anti-CGRP Monoclonal Antibodies in the Prevention of High-Frequency Episodic and Chronic Migraine in Romania—A Multicenter Retrospective Observational Study
In this Romanian real-world cohort, anti-CGRP monoclonal antibody treatment was associated with substantial reductions in migraine/headache frequency in patients with HFEM and CM, and generally well-tolerated.
Alin Ciubotaru, Albert Vamanu, Cristina Grosu et al.
· Biomedicines · 0 citations